Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach
Tim Dekker(Leiden University Medical Center), Marc J. van de Vijver(Amsterdam UMC Location University of Amsterdam)
Cited by 57
Related Papers
Current Perspectives on HER2 Testing: A Review of National Testing Guidelines
|Modern Pathology|2003|269
Reliability of core needle biopsy for determining ER and HER2 status in breast cancer
|Annals of Oncology|2012|78